Showing results (121-130 of 149) with videos related to
Sort By:
Pageof 15
European Urology Focus|September 27, 2022
Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation TherapyChung Un Lee, Eunhae Cho, Junnam Lee, et al.Radiation Oncology Journal|July 1, 2024
Hypofractionated radiation therapy combined with androgen deprivation therapy for clinically node-positive prostate cancerTae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.Journal of the American Society of Nephrology : JASN|August 12, 2022
KLC3 Regulates Ciliary Trafficking and Cyst Progression in CILK1 Deficiency-Related Polycystic Kidney DiseaseGyuyeong Rah, Hwayeon Cha, Joohee Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2023
CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion TherapySeung Hyuck Jeon, Minyong Kang, Minwoo Jeon, et al.Scientific Reports|April 8, 2024
Androgen deprivation alone versus combined with pelvic radiation for adverse events and quality of life in clinically node-positive prostate cancerTae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.Journal of Medical Imaging and Radiation Oncology|March 13, 2024
Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancerTae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.BMC Urology|May 5, 2019
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancerSang Eun Yoon, Youjin Kim, Jangho Cho, et al.Elife|May 1, 2019
Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancerSungEun Kim, Yubin Kim, JungHo Kong, et al.Journal of Personalized Medicine|November 27, 2021
Risk of Postoperative Gastrointestinal Bleeding and Its Associated Factors: A Nationwide Population-Based Study in KoreaSang Hyuck Kim, Kyungdo Han, Gunseog Kang, et al.Asian Journal of Urology|August 14, 2024
Optimal sequential therapy using tyrosine kinase inhibitors as the first-line treatment in patients with metastatic renal cell carcinoma: A nationwide multicenter studyJung Ki Jo, Seong Il Seo, MinYong Kang, et al.Pageof 15